Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
July 10, 2018
| By Diane Mapes / Fred Hutch News Service
Results from a large multicenter trial published today in JAMA offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.
Largest-ever study IDs risk factors, paves way for interventions to help
June 28, 2018
| By Susan Keown / Fred Hutch News Service
Being the caregiver of a loved one with a serious illness can be a tough job — and one that's too often under the radar. In a new study, Fred Hutch researchers take a hard look at how some of these "silent supporters" are doing.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.